MTOR and nonpapillary renal cell carcinoma: We used RCC4-EV cells that harbor inactivating VHL mutation, often found in clear cell RCC (CCRCC) [21] to generate a model of induced resistance to PI3K-mTOR kinase inhibitor BEZ235 [20].